Potential human health benefits of antibiotics used in food animals; a case study of virginiamycin. The virginiamycin market is flourishing due to the rapid increase in human population resulting in an increased demand for livestock. The growing livestock production has raised the demand for animal feed and virginiamycin in the global market. The virginiamycin market has been growing due to the necessity for the additional supplements in the diet for a companion as well as livestock animals for appropriate nutrition. The market is anticipated to showcase significant growth in the forecast period due to the rising demand for meat, milk, and poultry across the regions.
The growing population of pet owners among the middle-class population is expected to drive the market. The United States alone is the world’s largest beef producer, second largest pork producer along with a large number of dairy farms, poultry farms and alternative livestock. The rapid increase in livestock animals in the North America region is expected to upsurge the virginiamycin market growth.
Exceptional Advancement in Livestock Growth and Subsequently Increasing Demand for Virginiamycin
The shift in food consumption and dietary trends in livestock products is predominantly driving the current day world food economy. In the last several decades, the APEJ region has experienced a significant population increase leading to increased consumption of meat which has been growing at an alarming rate of 4% per annum. Apart from meat consumption, the demand for milk and dairy products have also experienced a demand growth by 2-3% per annum. Due to the increase in demand, there have been notable effects on the aggregate agricultural output. There has been a rapid increase in the livestock production consequently affecting the crop sector that supplies the virginiamycin feed. The virginiamycin feed demand has been considered as a dynamic element conditioning the growth, particularly in the developed regions. The growth in demand for animal feed and livestock itself has been raising the need for virginiamycin in the market to maintain the animal health devoid of side effects thereby aiding the market sales.
Rapid Advancements in Molecular Biology and Gene Sequencing Are Driving Researchers to Accomplish New Probiotic Applications for Animals
The technological advancements in the field of molecular biology and gene sequencing as allowing the researchers and scientists to develop new antibiotic formulas that are more adaptable for the animals. The virginiamycin supplements are undoubtedly beneficial for the animal growth and the gut health; however, the consumers still battle with several side-effects upon animal growth. The development of the new age technology is reforming the virginiamycin market providing better opportunities over the forecast period.
Emphatic Effects of Probiotic Supplementation in Animal Feed to Alternative Antibiotic Growth Promoters (AGP) such as Virginiamycin on Production Performance
Antibiotics have been used traditionally used around the globe in sub-therapeutic levels to counter microbial infections in animals subsequently improving their performance. However, due to the health concerns for humans as well as animals and the increase in antimicrobial resistance, these AGPs are either banned or restricted in several nations. The use of these AGPs such as virginiamycin is limited and restricted depending upon the region or country. Moreover, a vast consumer shift has been experienced towards probiotics.
Global Virginiamycin Market Segmentation
The global Virginiamycin market can be segmented on the basis of Animal as: Companion Animals Poultry Cattle Swine Aquaculture Other Animals The global Virginiamycin market can be segmented on the basis of the geographical region as:
North America Latin America Europe CIS & Russia Japan Asia Pacific excluding Japan (APEJ) Middle East & Africa (MEA) Global Virginiamycin Market Regional Overview
Markets in Europe, Middle East and Africa and Asia Pacific are expected to grow significantly over the forecast period. Consumption of Virginiamycin is relatively high among consumers in countries in the Europe region, which is expected to drive the Virginiamycin market growth in the near future. Increasing concerns about zero fat food products among consumers globally and changing consumption trends towards zero trans-fat food products in the young population are the factors expected to drive the growth of the global Virginiamycin market over the forecast period.
Among all the regional markets, North America is estimated to dominate the Virginiamycin market in terms of revenue share, followed by Europe and Asia Pacific. Asia Pacific and Latin America are expected to register higher growth in terms of value over the forecast period.
Some of the key market participants in the global Virginiamycin market are:
Phibro Animal Health Corporation Zoetis Elanco Merck Animal Health Merial Bayer Animal Health Virbac Ceva Boehringer Ingelheim Vetoquinol Other prominent players The research report presents a comprehensive assessment of the Virginiamycin market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to Virginiamycin market segments such as geographies, nature and end-use industries.
The Virginiamycin market report covers exhaustive analysis on:
Virginiamycin Market Segments Virginiamycin Market Dynamics Virginiamycin Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies involved Technology Value Chain Regional analysis for Virginiamycin Market includes:
North America (U.S., Canada) Latin America (Mexico, Brazil, Argentina, Chile, Peru, Rest of Latin America) Europe (Germany, Italy, France, U.K, Spain, BENELUX, Nordics, Eastern Europe, Rest of Europe) CIS and Russia Asia-Pacific (China, India, ASEAN, South Korea, Australia & New Zealand, Rest of APEJ) Japan Middle East and Africa (GCC Countries, South Africa, Turkey, Iran, Israel, Rest of MEA) The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments of Virginiamycin. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
Detailed overview of parent market Changing market dynamics in the industry In-depth market segmentation of Virginiamycin. Historical, current and projected market size of Virginiamycin in terms of volume and value Recent industry trends and developments Competitive landscape Strategies of key players and products offered Potential and niche segments, geographical regions exhibiting promising growth A neutral perspective on market performance Must-have information for market players to sustain and enhance their market footprint
